Cargando…

No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial

BACKGROUND: Obesity is associated with an increased risk for several chronic conditions and mortality. However, there are data in support of beneficial outcome in acute medical conditions such as community-acquired pneumonia (CAP), termed “obesity paradox”. The aim of this study was to test the asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borisov, Angel N., Blum, Claudine A., Christ-Crain, Mirjam, Ebrahimi, Fahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943130/ https://www.ncbi.nlm.nih.gov/pubmed/35322019 http://dx.doi.org/10.1038/s41387-022-00190-7

Ejemplares similares

Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial
por: Raess, Natalie, et al.
Publicado: (2021)

Association of Adrenal Function and Disease Severity in Community-Acquired Pneumonia
por: Mueller, Cornelia, et al.
Publicado: (2014)

Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia
por: Christ-Crain, Mirjam, et al.
Publicado: (2010)

Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial
por: Blum, Claudine A, et al.
Publicado: (2014)

Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies
por: Wittermans, Esther, et al.
Publicado: (2022)

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients
por: Kutz, Alexander, et al.
Publicado: (2014)

Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
por: Schuetz, Philipp, et al.
Publicado: (2010)

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
por: Müller, Beat, et al.
Publicado: (2007)

Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department
por: Fiumefreddo, Rico, et al.
Publicado: (2009)

Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study
por: Suter-Widmer, Isabelle, et al.
Publicado: (2012)

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
por: Christ-Crain, Mirjam, et al.
Publicado: (2006)

Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
por: Blum, CA, et al.
Publicado: (2015)

Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia
por: Schuetz, Philipp, et al.
Publicado: (2008)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome
por: Popovic, Milica, et al.
Publicado: (2020)

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia
por: Vögeli, Alaadin, et al.
Publicado: (2017)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study
por: Nickler, Manuela, et al.
Publicado: (2017)

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia
por: Baumgartner, Thomas, et al.
Publicado: (2018)

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study
por: Sbiti-Rohr, Diana, et al.
Publicado: (2016)

Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study
por: Zurfluh, Seline, et al.
Publicado: (2018)

OR2805 Plasma Sodium Increase Is Associated With An Increase In Bone Formation In Outpatients With Chronic SIAD—A Predefined Secondary Analysis Of The SANDx Trial
por: Monnerat, Sophie, et al.
Publicado: (2023)

Association of adrenal insufficiency with patient-oriented health-care outcomes in adult medical inpatients
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Copeptin Levels Remain Unchanged during the Menstrual Cycle
por: Blum, Claudine A., et al.
Publicado: (2014)

Paradoxical embolization secondary to acquired veno-venous malformations
por: Al-Sakini, Nada, et al.
Publicado: (2021)

Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment
por: Refardt, Julie, et al.
Publicado: (2021)

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
por: Ebrahimi, Fahim, et al.
Publicado: (2021)

Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke
por: Blum, Claudine A., et al.
Publicado: (2013)

EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome
por: Christ-Crain, Mirjam
Publicado: (2019)

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial
por: Schuetz, Philipp, et al.
Publicado: (2007)

Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial
por: Dinh, Aurélien, et al.
Publicado: (2021)

Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS
por: Borisov, Angel N, et al.
Publicado: (2023)

Obesity survival paradox in pneumonia: a meta-analysis
por: Nie, Wei, et al.
Publicado: (2014)

Validity of Different Copeptin Assays in the Differential Diagnosis of the Polyuria-Polydipsia Syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

2590. Efficacy of Doxycycline Versus Azithromycin in Community Acquired Pneumonia
por: Mei, Julie, et al.
Publicado: (2023)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s95rks1hgavpf9qnmilk2icqfe